Published:
Volcano Presentation at Thomas Weisel Conference to Be Webcast
SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Volcano Corporation
(Nasdaq: VOLC), a leading manufacturer and developer of intravascular
ultrasound (IVUS), functional measurement (FM) and Optical Coherence
Tomography (OCT) products designed to enhance the diagnosis and treatment of
coronary and peripheral vascular disease, said today that it will be
participating in the Thomas Weisel Partners 2008 Healthcare Conference on
Thursday, September 4.
The presentation by Scott Huennekens, president and chief executive
officer, will begin at 3:50 p.m., Eastern Daylight Time (12:50 p.m., Pacific
Daylight Time).
The presentation will be available through the conference website at
http://www.veracast.com/webcasts/twp/healthcare08/54213429.cfm or via the
company's website at http://www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices
designed to facilitate endovascular procedures, enhance the diagnosis of
vascular and structural heart disease and guide optimal therapies. The
company's intravascular ultrasound (IVUS) product line includes ultrasound
consoles that can be integrated directly into virtually any modern cath lab.
Volcano IVUS offers unique features, including both single-use phased array
and rotational IVUS imaging catheters, and advanced functionality options,
such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also provides
functional measurement (FM) consoles and single-use pressure and flow guide
wires and is developing a line of ultra-high resolution Optical Coherence
Tomography (OCT) systems and catheters. Currently, more than 3,500 Volcano
IVUS and FM systems are installed worldwide, with approximately half of its
revenues coming from outsidethe United States. For more information, visit
the company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily News
Tags: ,HEA,MTC,BIO,TDS,CCA,CA-Volcano-at-Confrnc